BPIQ Blog

Jul 1, 20181 min read

ZGNX imminently releasing more Ph3 data in a severe form of childhood epilepsy

Zogenix (ZGNX) is set to imminently release additional phase 3 data from its trial with its drug ZX008 (low dose fenfluramine) for...

Our platform helps you uncover your next biotech investment opportunity

bottom of page